NCT02745483View on ClinicalTrials.gov

Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies: Follow-up Study

PHASE2CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

December 31, 2015

Conditions
Hepatocellular Carcinoma
Interventions
DEVICE

Separable clustered electrodes

patients who signed informed consent, RFA was performed using separable clustered electrodes (Octopus®) in which, inter-tine distances can be flexibly adjusted by an operator.

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02745483 - Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies: Follow-up Study | Biotech Hunter | Biotech Hunter